Business · 17/12/1998Updated: 10/17/2026 · 1 min read
FDA Determines Regulatory Review Period for Silicone AMO ARRAY Multifocal IOL
Summary
The Food and Drug Administration has officially set a regulatory review period for the Silicone AMO ARRAY multifocal intraocular lens, following a patent extension application submitted to the US Patent and Trademark Office.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →